967 resultados para BI-1
Resumo:
Doze modelos matemáticos (seis bi-paramétricos e seis tri-paramétricos), amplamente utilizados na predição de isotermas, foram estudados, com o objetivo de predizer isotermas de adsorção de umidade do guaraná (Paullinia cupana) em pó, obtido em "sprey dryer". As isotermas de adsorção de umidade do produto à 15° C, 25° C e 35° C, foram ajustadas por análise de regressão não-linear, usando o aplicativo STATGRAPHICS 5.1. Entre os modelos testados os que apresentaram melhores resultados nos ajustes foram as equações tri-paramétricas de GAB, BET modificada e Anderson, e as equações bi-paramétricas de Handerson e Oswin.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
In this work we studied the synthesis of BSCCO-2212 superconducting phase associating a quite similar method developed by Pechini with the microwave-assisted hydrothermal method. To study the influence of the microwaves on the properties of BSCCO system, we synthesized two samples by such method. For one sample we used carbonates and for the other one we used nitrates as chemical reagents. We also produced a reference sample just using carbonates by Pechini's method to compare their morphological and superconducting properties. The structural properties of the samples were analyzed by scanning electron microscopy and X-ray diffraction. The Bi-2212 phase is predominant in all samples and despites the nitrates-like sample has a broader distribution of grain size in comparison with the reference sample, its magnetic behaviour is closer to that presented by the reference one.
Resumo:
Since the discovery of YBaCuO, experiments have shown that its superconducting properties are strongly affected by the oxygen content. More recently, anelastic relaxation measurements in La2CuO4+δ, showed that the decrease in the oxygen content can be related to two events. One is the decrease in mobility between two adjacent CuO planes, and the other is the increase in the number of tilting patterns of the CuO6 octahedra. In the case of the bismuth-based ceramic, it is known that the oxygen content, within some limits, does not affect its superconducting properties. In order to evaluate the mobility and the effect of the oxygen content on this material we have prepared BSCCO ceramic and tested regarding its internal friction and electrical resistivity as a function of the temperature while the oxygen content was being reduced by a sequence of vacuum annelaing at 620 K. The samples were prepared in the Bi:Sr:Ca:Cu = 2212 and 2223 proportion, using powder obtained by the sol-gel route and conventional solid state reaction. The anelastic relaxation measurements were performed using a torsion pendulum operating with frequency about 15-35 Hz between 77 to 700 K. The diffraction pattern of the as sintered and the vacuum annealed material were also presented. The results have shown complex anelastic relaxation structures that were associated to the jump of interstitial oxygen atoms between two adjacent CuO planes. The vacuum annealing showed to be deleterious to the critical temperature of the superconducting ceramic.
Resumo:
The spark plasma sintering (SPS) technique, by using a compacting pressure of 50 MPa, was used to consolidate pre-reacted powders of Bi1.65Pb0.35Sr2Ca2Cu3O10+delta (Bi-2223). The influence of the consolidation temperature, T-D, on the structural and electrical properties has been investigated and compared with those of a reference sample synthesized by the traditional solid-state reaction method and subjected to the same compacting pressure. From the X-ray diffraction patterns, performed in both powder and pellet samples, we have found that the dominant phase is the Bi-2223 in all samples but traces of the Bi2Sr2CaCu2O8+x (Bi-2212) were identified. Their relative density were similar to 85% of the theoretical density and the temperature dependence of the electrical resistivity, rho(T), indicated that increasing T-D results in samples with low oxygen content because the SPS is performed in vacuum. Features of the rho(T) data, as the occurrence of normal-state semiconductor-like behavior of rho(T) and the double resistive superconducting transition, are consistent with samples comprised of grains with shell-core morphology in which the shell is oxygen deficient. The SPS samples also exhibited superconducting critical current density at 77 K, J(c)(77K), between 2 and 10A/cm(2), values much smaller than similar to 22A/cm(2) measured in the reference sample. Reoxygenation of the SPS samples, post-annealed in air at different temperatures and times, was found to improve their microstructural and transport properties. Besides the suppression of the Bragg peaks belonging to the Bi-2212 phase, the superconducting properties of the post-annealed samples and particularly J(c)(77K) were comparable or better than those corresponding to the reference sample. Post-annealed samples at 750 degrees C for 5min exhibited J(c)(77K) similar to 130A/cm(2) even when uniaxially pressed at only 50 MPa. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4768257]
Resumo:
Melanoma is one of the most treatment-resistant malignancies and regardless of new therapeutic tactics the outcome remains dismal. Polo-like kinase 1 (PLK1) has been shown to be over-expressed in a variety of tumors, becoming an attractive target for cancer management. In the present study we tested the in vitro antitumor activities of BI 2536, a selective inhibitor of PLK1, against two melanoma cell lines. Our results showed that nanomolar concentrations (10-150 nmol/L) of the drug significantly decreased cell proliferation and clonogenicity, promoting cell cycle arrest in G2/M. Targeting the cell cycle offers an attractive potential cancer-treatment option. Herein we show that PLK1 inhibition may be a feasible approach for the impairment of tumor progression and dissemination. This in vitro profile of melanoma cell growth inhibition by PLK1 modulation may be an interesting model to be tested in association with first-line antineoplasic agents in melanomas.
Resumo:
The monodentate cis-[Ru(phen)(2)(hist)(2)](2+) 1R and the bidentate cis-[Ru(phen)(2)(hist)](2+) 2A complexes were prepared and characterized using spectroscopic (H-1, (H-1-H-1) COSY and (H-1-C-13) HSQC NMR, UV-vis, luminescence) techniques. The complexes presented absorption and emission in the visible region, as well as a tri-exponential emission decay. The complexes are soluble in aqueous and non-aqueous solution with solubility in a buffer solution of pH 7.4 of 1.14 x 10(-3) mol L-1 for (1R + 2A) and 6.43 x 10(-4) mol L-1 for 2A and lipophilicity measured in an aqueous-octanol solution of -1.14 and -0.96, respectively. Photolysis in the visible region in CH3CN converted the starting complexes into cis-[Ru(phen)(2)(CH3CN)(2)](2+). Histamine photorelease was also observed in pure water and in the presence of BSA (1.0 x 10(-6) mol L-1). The bidentate coordination of the histamine to the ruthenium center in relation to the monodentate coordination increased the photosubstitution quantum yield by a factor of 3. Pharmacological studies showed that the complexes present a moderate inhibition of AChE with an IC50 of 21 mu mol L-1 (referred to risvagtini, IC50 181 mu mol L-1 and galantamine IC50 0.006 mu mol L-1) with no appreciable cytotoxicity toward to the HeLa cells (50% cell viability at 925 mu mol L-1). Cell uptake of the complexes into HeLa cells was detected by fluorescence confocal microscopy. Overall, the observation of a luminescent complex that penetrates the cell wall and has low cytotoxicity, but is reactive photochemically, releasing histamine when irradiated with visible light, are interesting features for application of these complexes as phototherapeutic agents.
Resumo:
Lo scopo di questo lavoro è stato quello di studiare dettagliatamente la reattività dell’N-benzilossicarbonil-1-aza-butadiene, utilizzando diversi dienofili in reazioni di Diels-Alder catalitiche enantioselettive promosse da organocatalizzatori bifunzionali in grado di dare interazioni deboli come legami a idrogeno. Questo 1-azadiene infatti può dare in linea di principio sia prodotti derivanti da reazioni di Diels-Alder a domanda elettronica diretta in cui funge da diene, sia reazioni a domanda elettronica inversa in cui il doppio legame terminale dell’1-azadiene, maggiormente reattivo in quanto meno ingombrato, funge da olefina elettronricca (reazione di Povarov). Per effettuare questo studio sono stati provati vari dienofili tra cui olefine elettron povere bi- e monosostituite che portavano alla degradazione del diene; derivati della malimmide e del pirazolo che davano cilcloaddotti derivanti dalla classica cicloaddizione [4+2] Diels-Alder con ottime conversioni in modo altamente diastereoselettivo, ma bassi eccessi enantiomerici ed infine si sono provate diverse immine che portavano al cicloaddotto della reazione di Povarov con ottimi risultati in termini di conversione e buoni eccessi enantiomerici. Quest’ultima applicazione che permette la sintesi di interessanti prodotti variamente funzionalizzabili, sarà oggetto di studio in futuro per ottimizzare le condizioni della reazione.
Resumo:
La tesi riguarda lo sviluppo di un'applicazione che estende la possibilità di effettuare i caricamenti dei package di SAP BPC ai dispositivi mobile, fino ad ora questo era possibile solo attraverso l'interfaccia di Microsoft Excel.
Resumo:
In der Dissertation konnte gezeigt werden, dass von einem pp65(495-503)-spezifischen Doppelketten-TZR (2-Plasmide-retrovirales Vektorsystem) ein Potential der Fremdinteraktion mit spezifitätsfremden humanen gp100(280-288)- und AML(14-22)- sowie murinen MDM2(81-88)- und p53(264-272)-Tumorantigen-spezifischen TZRa und -b Ketten besteht. Folglich zeichneten sich essentielle Optimierungsverfahren ab. Für die Generierung von bi-spezifischen T-Zellenrnwurden zwei Strategien etabliert. Das erste Verfahren hatte zur Voraussetzung, dass der Donor und Rezipient einen HCMV-seropositiven Status aufweisen würden. Es ließen sich pp65(495-503)-spezifische T-Zellen aus HCMV-seropositiven Blutproben expandieren, die eine effiziente pp65(495-503)-Spezifität charakterisierte. In der zweiten Strategie wurde die Situation behandelt, dass der Donor HCMV-seronegativ und der Rezipient HCMV-seropositiv wären.rnHierbei wurde das Verfahren der simultanen Kotransfektion mit einem pp65(495-503)- und p53(264-272)-spezifischen TZR etabliert. Bei der Verwendung beider Strategien konnten effizient p53(264-272)-Tumorantigen und pp65(495-503)-bi-spezifische T-Zellen generiert werden.rnHinzukommend konnte der Einfluss einer möglichen Kompetition um CD3 undrnFehlinteraktion mit den endogenen TZRa und -b Ketten dargelegt werden. Des Weiteren erfolgten Interaktionsanalysen mit einem p53(264-272)-Tumorantigen-spezifischen Einzelketten-TZR. Die Analysen erfolgten sowohl unter nicht-kompetitiven Bedingungen in der humanen Jurkat-76 Zelllinie, welche den genomischen Verlust von endogenen TZRa und -b Ketten kennzeichnete, als auch unter kompetitiven Bedingungen in den humanen T-Zellen, die endogene TZRa und -b Ketten besitzen. In dem 2-Plasmide-retroviralen Vektorsystem konnte gezeigt werden, dass unter nicht-kompetitiven Bedingungen der p53(264-272)- Tumorantigen-spezifische Einzelketten-TZR in erhöhtem Maße mit der murinen MDM2(81-88)-sowie homologen p53(264-272)- als auch mit den humanen TZRa Ketten der Spezifitäten AML(14-22), gp100(280-288) und pp65(495-503) (Vb3-Analyse) interagieren konnte. Interessanterweise zeigte sich im 1-Plasmid-retroviralen Vektorsystem ein geringeres Interaktionsverhalten mit murinen und vor allem humanen TZRa Ketten. Das Interaktionspotential schien TZR Subfamilien-abhängig zu sein. Essentiell war es, dass der p53(264-272)-Tumorantigenspezifische Einzelketten-TZR eines 1-Plasmid-retroviralen Vektorsystems, trotz minimaler Beeinflussungen, stets an der Zelloberfläche exprimiert werden konnte und sich kein vollständiger Verlust der p53(264-272)-Spezifität verzeichnen ließ. Aufgrund der Verdrängung der Va-Domäne des p53(264-272)-Tumorantigen-spezifischen Einzelketten-TZR durch eine Volllängen-TZRa-Kette, erfolgte die Optimierung der Va/Vb-Interaktion des Einzelketten-TZR (1-Plasmid-retrovirales Vektorsystem). Es konnte ein neuartiger p53(264-272)-Tumorantigenspezifischer Einzelketten-TZR mit einer zusätzlichen künstlichen Disulfidbrücke zwischen Va(Q51C) und dem C-terminalen Ende des SL7-Linkers (G16C) generiert werden. Dieser Einzelketten-TZR zeigte im Vergleich zum Ausgangskonstrukt eine stärkere Va/Vb-Bindung, ausgelesen an einer effizienten Reduktion der residuellen Kettenfehlinteraktion, sowie eine effiziente TZR-Expression und Funktionalität, als auch eine vergleichbare TZR-MHC:Peptid-Affinität. Zusammenfassend konnten pp65(465-503)- und p53(264-272)-Tumorantigen-bi-spezifische T-Zellen generiert werden, die eine effiziente duale Spezifität aufwiesen. Auch konnte detailliert das Interaktionsverhalten eines p53(264-272)-Tumorantigen-spezifischen Einzelketten-TZR mit spezifitätsfremden TZRa Ketten dargelegt sowie eine Optimierung eines p53(264-272)-Tumorantigen-spezifischen Einzelketten-TZR (1-Plasmid-retrovirales Vektorsystem) erzielt werden.
Resumo:
PURPOSE: Malignant glial brain tumors consistently overexpress neurokinin type 1 receptors. In classic seed-based brachytherapy, one to several rigid (125)I seeds are inserted, mainly for the treatment of small low-grade gliomas. The complex geometry of rapidly proliferating high-grade gliomas requires a diffusible system targeting tumor-associated surface structures to saturate the tumor, including its margins. EXPERIMENTAL DESIGN: We developed a new targeting vector by conjugating the chelator 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid to Arg(1) of substance P, generating a radiopharmaceutical with a molecular weight of 1,806 Da and an IC(50) of 0.88 +/- 0.34 nmol/L. Cell biological studies were done with glioblastoma cell lines. neurokinin type-1 receptor (NK1R) autoradiography was done with 58 tumor biopsies. For labeling, (90)Y was mostly used. To reduce the "cross-fire effect" in critically located tumors, (177)Lut and (213)Bi were used instead. In a pilot study, we assessed feasibility, biodistribution, and early and long-term toxicity following i.t. injection of radiolabeled 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid substance P in 14 glioblastoma and six glioma patients of WHO grades 2 to 3. RESULTS: Autoradiography disclosed overexpression of NK1R in 55 of 58 gliomas of WHO grades 2 to 4. Internalization of the peptidic vector was found to be specific. Clinically, the radiopharmeutical was distributed according to tumor geometry. Only transient toxicity was seen as symptomatic radiogenic edema in one patient (observation period, 7-66 months). Disease stabilization and/or improved neurologic status was observed in 13 of 20 patients. Secondary resection disclosed widespread radiation necrosis with improved demarcation. CONCLUSIONS: Targeted radiotherapy using diffusible peptidic vectors represents an innovative strategy for local control of malignant gliomas, which will be further assessed as a neoadjuvant approach.